Lv41
430 积分 2024-04-27 加入
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
36分钟前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
39分钟前
已完结
A Phase 1, Single‐Dose Study to Evaluate the Pharmacokinetics and Safety of Bepirovirsen in Adults with Hepatic Impairment and Healthy Participants (B‐Assured)
1小时前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
10天前
已完结
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
13天前
已完结
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
2个月前
已完结
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
2个月前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
3个月前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
4个月前
已完结
皖公网安备34019202002308
